Post-Market Clinical Investigation of NanoFUSE® Bioactive Matrix
Phase 4
- Conditions
- Bone; Degeneration
- Interventions
- Device: NanoFUSE® Bioactive Matrix
- First Posted Date
- 2018-12-04
- Last Posted Date
- 2018-12-04
- Lead Sponsor
- NanoFUSE Biologics, LLC
- Target Recruit Count
- 100
- Registration Number
- NCT03762811
NanoFUSE® PL Gutter PMCF
Phase 4
- Conditions
- Degenerative Disc Disease
- Interventions
- Device: NanoFUSE® Bioactive Matrix (75%) w/autograft (25%)
- First Posted Date
- 2018-11-23
- Last Posted Date
- 2018-11-23
- Lead Sponsor
- NanoFUSE Biologics, LLC
- Target Recruit Count
- 50
- Registration Number
- NCT03751943
© Copyright 2025. All Rights Reserved by MedPath